✦ LIBER ✦

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial

✍ Scribed by Giulio G Stefanini; Bindu Kalesan; Patrick W Serruys; Dik Heg; Pawel Buszman; Axel Linke; Thomas Ischinger; Volker Klauss; Franz Eberli; William Wijns; Marie-Claude Morice; Carlo Di Mario; Roberto Corti; Diethmar Antoni; Hae Y Sohn; Pedro Eerdmans; Gerrit-Anne van Es; Bernhard Meier; Stephan Windecker; Peter Jüni

Book ID: 117309438
Publisher: The Lancet
Year: 2011
Tongue: English
Weight: 286 KB
Volume: 378
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(11)61672-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biolimus-eluting stent with biodegradabl

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

✍ Stephan Windecker; Patrick W Serruys; Simon Wandel; Pawel Buszman; Stanislaw Trz 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 227 KB

SIROLIMUS ELUTING STENT WITH BIODEGRADAB

SIROLIMUS ELUTING STENT WITH BIODEGRADABLE POLYMER VERSUS SIROLIMUS ELUTING STENT WITH DURABLE POLYMER FOR THE TREATMENT OF PATIENTS WITH DE NOVO CORONARY ARTERY LESIONS (EVOLUTION): A RANDOMIZED NON-INFERIORITY TRIAL

✍ Junbo Ge; Lei Ge; Juying Qian; Guosheng Fu; Huiliang Liu; Genshan Ma; Yitong Ma; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 106 KB

One-Year Clinical Outcome of a Randomize

One-Year Clinical Outcome of a Randomized Trial of Polymer-Free Paclitaxel-Eluting Stents Versus Biodegradable Polymer-Based Rapamycin-Eluting Stents in Patients with Coronary Heart Disease

✍ LAN ZHANG; JIA YUAN; GAN LIU; JIN-PENG ZHONG; YUE-HUI YIN; QIANG SH 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

LONG-TERM OUTCOMES OF BIODEGRADABLE POLY

LONG-TERM OUTCOMES OF BIODEGRADABLE POLYMER DRUG-ELUTING STENTS VERSUS DURABLE POLYMER SIROLIMUS-ELUTING STENTS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: A POOLED ANALYSIS OF INDIVIDUAL PATIENT DATA FROM THE ISAR-TEST 4 AND LEADERS RANDOMIZED TRIALS

✍ Giulio G. Stefanini; Robert Byrne; Patrick Serruys; Antoinette de Waha; Bernhard 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 105 KB

BIODEGRADABLE POLYMER DRUG-ELUTING STENT

BIODEGRADABLE POLYMER DRUG-ELUTING STENTS VERSUS DURABLE POLYMER SIROLIMUS-ELUTING STENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A POOLED ANALYSIS OF INDIVIDUAL PATIENT DATA FROM THE ISAR-TEST 3, ISAR-TEST 4, AND LEADERS RANDOMIZED TRIALS AT 4 YEARS

✍ Robert A. Byrne; Giulio Stefanini; Patrick Serruys; Antoinette de Waha; Bernhard 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Late-Term Clinical Outcomes With Zotarol

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

✍ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 704 KB